TRIP SIG is a special interest group for anyone who has an interest in implementation science in the clinical trials sector.
Mission:
TRIP SIG’s mission is to enhance the translation of evidence from clinical trials into clinical practice in Australia.
Purpose:
TRIP SIG provides a support network and collaborative community for implementation science professionals in clinical trial teams, as well as other professionals interested in embedding implementation science methods and strategies in trials. It is a forum for members to share knowledge and expertise, identify issues, exchange information, and engage in collaborative problem-solving.
The group acts to:
- support professional development needs of the clinical trial workforce to enhance implementation science in trials capability
- promote the importance of embedding implementation science into clinical trial design
- improve the quality of clinical trials and the translation of evidence into clinical practice, through promoting implementation science methodologies
Membership:
Membership of TRIP SIG is open to implementation science professionals in clinical trial teams and anyone else interested in implementation science in trials. Please email acta@acta.au if you would like to join.
National Needs Assessment Survey: Identifying the Implementation Science Research and Practice Training Needs of the Clinical Trial Workforce.
The clinical trial workforce is a critical cog in the wheels of evidence generation, implementation and translation. Implementation science and practice has the potential to design and deliver trials that are more likely to be translated for impact in the community.
AIM: To determine, across the ANZ clinical trials workforce, familiarity and understanding of implementation science, interest to upskill in methodologies, and barriers to, and preferences for, accessing support.
Results of Needs assessment: 353 responses were received across diverse geographies, professions, and clinical areas. Over 40% of respondents were unsure what implementation science means. Most participants were familiar with some methodologies but had limited direct experience. Appetite for implementation science training was high, particularly for topics such as embedding implementation in trial design, recruitment strategies, sustainment, translation and scalability. Barriers to receiving training were cost, travel and time, hence preferred formats were short online/ hybrid workshops.
Priorities for the TRIP-SIG are to raise awareness of how implementation science is relevant to clinical trial teams and informing the needs for accessible training to support use of implementation methodologies in trial design and delivery.